BCG vaccine for clinically isolated syndrome and MS: Infections and protective immunity

Neurology

Volumn 82, Issue 1, 2014, Pages 15-16

  Bourdette, Dennis ^a   Naismith, Robert T ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BETA1A INTERFERON; GADOLINIUM; IMMUNOSUPPRESSIVE AGENT; PLACEBO;

BCG VACCINATION; BOVINE TUBERCULOSIS; CLINICAL TRIAL (TOPIC); CONTRAST ENHANCEMENT; DEMYELINATING DISEASE; DISEASE ACTIVITY; EDITORIAL; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

EID: 84892159742     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000438232.40847.c3     Document Type: Editorial

References (10)

1. Correale J, Fiol M, Gilore W. The risk of relapses in multiple sclerosis during systemic infections. Neurology 2006; 67:652-659. (Pubitemid 44273613)
2. Fleming J, Fabry Z. The hygiene hypothesis and multiple sclerosis. Ann Neurol 2007;61:85-89. (Pubitemid 46363834)
3. Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007;61:97-108. (Pubitemid 46363837)
4. Ristori G, Romano S, Cannoni S, et al. Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS. Neurology 2014;82:41-48.
5. Kawai K, Miyazaki J, Joraku A, Nishiyama H, Akaza H. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered vaccine. Cancer Sci 2013;104:22-27.
6. Faustman DL, Wang L, Okubo Y, et al. Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes mellitus. PLoS One 2012 7:e41756.
7. Sewell DL, Reinke EK, Co D, et al. Infection with Mycobacterium BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis. Clin Diagn Lab Immunol 2003;10:564-572. (Pubitemid 36890439)
8. Hesseling AC, Rabie H, Marais BJ, et al. Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIVuninfected children. Clin Infect Dis 2006;42:548-558. (Pubitemid 43202529)
9. Ben-Nun A, Mendell I, Sappler G, Kerlero de Rosbo N. A 12-KDa protein of Mycobacterium tuberculosis protects mice against experimental autoimmune encephalomyelitis: protection in the absence of shared T cell epitopes with encephalitogenic proteins. J Immunol 1995;154: 2939-2948.
10. Lagranderie M, Abolhassani M, Vanoirbeek JA, et al. Mycobacterium bovis bacillus Calmette-Guerin killed by extended freeze-drying targets plasmacytoid dendritic cells to regulate lung inflammation. J Immunol 2010;184: 1062-1070.